Sanofi S.A. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other pharmaceutical manufacturers in Europe: Bayer AG of Germany (2012 sales of 39.76 billion Euro [US$51.04 billion] of which 29% was Material Science), Roche Holding Aktiengesellschaft of Switzerland (45.50 billion Swiss Francs [US$46.81 billion] of which 77% was Pharmaceuticals), and GlaxoSmithKline plc which is based in the United Kingdom (£26.43 billion [US$40.11 billion] of which 81% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2012, sales at Sanofi S.A. were 34.95 billion Euro (US$44.86 billion). This is an increase of 4.7% versus 2011, when the company's sales were 33.39 billion Euro. This was the fourth straight year of sales growth at Sanofi S.A.. Sales of Vaccines saw an increase that was more than double the company's growth rate: sales were up 12.3% in 2012, from 3.47 billion Euro to 3.90 billion Euro. Sanofi S.A. also saw significant increases in sales in Animal Health (up 7.3% to 2.18 billion Euro) .
Business Description